Werkgroep Cardiologische centra Nederland

PROGRESS (Completed)

A Phase 2 Randomized, Double-Blinded, Placebo-Controlled Study to Evaluate the Effects of Multiple Subcutaneous Injections of Elamipretide on Left Ventricular Function in Subjects with Stable Heart Failure with Reduced Ejection Fraction
Medicine
elamipretide
Population
Heart failure
Phase
II
Starting year
2015
More information
ClinicalTrials.gov

Director of Study

dr. D.J.A. Lok (Cardioloog)
Deventer, Deventer Ziekenhuis